Exam (elaborations)

NUR 317 Med Surg 1 Exam 3 Study Guide- Ch. 48, 49, 32, 37: Diabetes; Thyroid; Adrenal Gland; Hyper/hypotension; Vascular Disorders

7 views 0 purchase

Course
NUR 317 Med Surg 1

Institution
NUR 317 Med Surg 1

NUR 317 Med Surg 1 Exam 3 Study Guide- Ch. 48, 49, 32, 37: Diabetes; Thyroid; Adrenal Gland; Hyper/hypotension; Vascular Disorders NUR 317 EXAM 3 Lewis Chapter 48/ Diabetes: 1. Describe the prevalence and incidence of diabetes mellitus. ● Diabetes mellitus is the seventh leading cause of d...

[Show more]

Preview 4 out of 32 pages

View example

Uploaded on July 29, 2024
Number of pages 32
Written in 2023/2024
Type Exam (elaborations)
Contains Questions & answers

nur 317 med surg 1
nur 317 med surg 1 exam 3 study guide ch 48 49

Institution NUR 317 Med Surg 1
Course NUR 317 Med Surg 1

Wisdoms

Member since 9 months 141 documents sold

195

CA$23.74

Added

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

NUR 317 Med Surg 1 Exam 3 Study Guide - Ch., 49, 32, 37: Diabetes; Thyroid; Adrenal Gland; Hyper/hypotension; Vascular Disorders NUR 317 EXAM 3 Lewis lChapter l48/ lDiabetes: 1. Describe lthe lprevalence land lincidence lof ldiabetes lmellitus. ● Diabetes lmellitus lis lthe lseventh lleading lcause lof ldeath lin lthe lU.S., lbut lit lis llikely lto lbe lunderreported land lunderdiagnosed. l 2. What lare lthe lmajor lorgans laffected lby lthe llack lof ltight lglucose lcontrol land lhow lare lthey laffected lnegatively? ● Tight lglucose lcontrol: lreduced ltheir lrisk lfor lthe ldevelopment lof lretinopathy land lnephropathy. l ○ Treatment lgoals lto lmaintain lblood lglucose llevels las lnear lto lnormal las lpossib le l(keep lA1C lless lthan l7) ○ 9 lis lnot lwell lcontrolled l ● Lack lof ltight lglucose lcontrol leffects: leyes, lkidneys, land lblood lvessels l 3. Review lthe lpathophysiology, lrisk lfactors, lmanifestations lof ltype l1 land ltype l2 ldiabetes. l ● Type lI l ○ Caused lby lautoimmune ldestruction lof lthe lpancreatic lB-cells l ■ B-Cells: lsite lof linsulin lproduction ○ Results lin lTOTAL labsence lof linsulin lproduction ○ Generally ldiscovered l<30 lyears lold l ○ Manifestations: lpolyuria, lpolydipsia, lpolyphagia l ■ Polyuria l→ lglucose l(increased lin lthe lbloodstream) l ● osmotic leffect l(increased lurination land lthirst) ■ Polydipsia l(increased lthirst) l→ ldue lto ldehydration ■ Polyphagia l→ lIncreased lhunger ● Consequence lof lcellular lmalnourishment l ● Glucose lcan’t lget linto lcells land lbe lused lso lthe lbody luses lfats land lprotein lfor lenergy l ■ Weight lloss, lfatigue, lfrequency lof linfections, lrapid lonset l ■ Late, lautoantibodies lto lthe lislet lcells lcause la lreduction lof l80% lto l90% lof lnormal lfunction. l ● Type lII l ○ The lMOST lprevalent l ○ Pancreas lproduces linsulin l→ lbut lnot lenough l(beta lcells lbecome lfatigued lafter lmass lis llost) l ○ Insulin lis lpoorly lused lby lthe ltissues, laltered lglucose, land lfat lmetabolism l ○ Defective linsulin lreceptors lunresponsive land linsufficient l ■ (decreased luptake= lincreased lglucose linto lcirculation l= lhyperglycemia) ○ Risk lFactors l ■ Obesity, lsedentary llifestyle l ■ Age, lethnicity l→ lAsian, lAfrican lAmerican, lNative lAmericans, lor lfamily lhx l ■ Diagnosed l→ lgradually lfind lwith lblood ltest lA1C l l 4. Identify lthe ldiagnostics ltests lused lfor lscreeni ng, ldiagnosis, land lmonitoring ldiabetes. ● Pancreatic lstudies l(Fasting lBlood lGlucose l(FBG) ● Oral lGlucose lTolerance lTest l(OGTT) ● Hemoglobin lA1C l(Hb lA1C) ○ This ltest loffers lthe lBEST linformation labout lglucose lcontrol l ○ Measures lamount lof lglucose lthat lis lattached lto lhemoglobin l(RBC) ■ 9 lis lnot lcontrolled l ○ Shows lglucose lcontrol lover l2-3 lmonths l(90 ldays) linstead lof lsnapshot l ● Microalbuminuria ○ Yearly lurine lscreening l ○ Spilling lout lalbumin linto lurine lbecause lglomeruli lare ldamaged l ● Urine lglucose ● Ketones ○ Acids lfrom lbreakdown lof lfat l→ lcause lacidosis ○ Ketones lare lacidic lby-products lof lfat lmetabolism ● Ketonuria lis la lprocess lthat loccurs lwhen lketone lbodies lare lexcreted lin lthe lurine l 5. Identify lvarious loral lantidiabetic lmedication lclassifications, lhow lthey lwork land lan lexample lof leach. l(those lnames llisted lon lPP lslides). ● Thiazolidinediones l(pioglitazone) ○ Decrease lendogenous lglucose lproduction, lincreases linsulin lsensitivity l ○ Watch lfor lcardiac levent l ○ Do lNOT lcause lhypoglycemia lwhen lused lalone l ● a-Glucosidase lInhibitors : l(acarbose, lmiglitol) ○ Slow ldown labsorption lof lcarbohydrate lin lsmall lintestine l ○ Reduces lpost lmeal lhyperglycemia ○ GI lupset l* ● DPP4 -Inhibitors l ○ Increase linsulin lsynthesis land lrelease, ldecrease lhepatic lglucose lproduction ○ Lower lthe lpotential lfor lhypoglycemia l(because lthey lare lglucose ldependent) l ○ GI lupset l a. What lis limportant lto lremember lwhen lcaring lfor la lclient ltaking lsulfonylureas lor lmeglitinides? ● Sulfonylureas : l(glipizide, lglimepiride, lglyburide) l ○ Stimulates linsulin lrelease lfrom lpancreas * l→ ldecreased lBG l ○ Increase ltissue lsensitivity lto linsulin l ○ Side leffects: lHypoglycemia l→ lcommon l* ○ Beta-blockers lcan lmask l(signs lof lhypoglycemia)* ○ Take l30 lminutes lprior lto lmeals l ○ Avoid lalcohol l ● Meglitinides l(repaglinide, lnateglinide) l ○ Stimulates linsulin lrelease lfrom lpancreas l* ○ Administer l15-30 lmin lbefore lmeal* ○ Omit ldose lif lmeal lis lskipped l→ lprevent lhypoglycemia* l ○ SE: lhypoglycemia; lless llikely lthan lsulfonylureas l* b. What lis limportant lto lremember lwhen lcaring lfor la lclient ltaking lthe lbiguanide: lmetformin lregarding ldiagnostic ltests. ● Biguanide l(Metformin): l ○ IV lcontrast liodine l→ lrisk lfor lacute lkidney linjury l ■ Stop lit l2 ldays lbefore land lwait l2 ldays lafter ○ Reduce lglucose lproduction lby lliver l ○ Increases ltissue lsensitivity lto linsulin l ○ Slows lcarb. lAbsorption lin lintestine l ○ Improve lglucose ltransportation linto lcells l ○ May lcause lmoderate lweight lloss l ○ LACTIC lACIDOSIS l ○ First-choice ldrug lfor lmost ltype l ○ Not lused lwith lkidney ldisease l ○ Take lwith lfood l ○ D/c lbefore lprocedure lwith lcontrast lmedium l→ luntil l48 lhours lafterward l* ○ First lchoice ldrug lfor lmost lpeople lwith ltype l2 ldiabetes 6. Discuss lthe lonset, lpeak, land lduration lof lthe lfollowing ltypes lof linsulins: l(use lATI lpharm lbook las lyour lreference) a. Rapid -acting : llispro l(Humalog)/aspart l(Novolog) ● Most lrapid lonset lof laction l(15-30 lminutes) ● Peaks lin l1-3 lhours l ● DOA: l3-6 lhours l ● MUST lbe ladministered lwithin l5 lminutes lbefore la lmeal* ● Clear l b. Short -acting : lregular l(Humulin lor lNovulin) lreplace lmeal ● Onset: l30-60 lminutes l ● Peak: l1-5 lhours ● DOA: l6-10 lhours l ● ONLY lone lyou lcan lgive lIV lbolus, lIV linfusion, lor lIM* ● Clear l c. Intermediate : lNPH/humulin lN ● Onset: l1-2 lhours ● Peak: l6-14 lhours ● DOA: l16-24 lhours l ● Cloudy l ○ Never lshake lthem, ldecrease lability lto labsorb, lroll lthem l d. Long -acting : lglargine l(Lantus) ● Onset: l70 lminutes l ● Peak: lNONE* ● Duration: l24 lhours l ○ Administered lonce la lday l(SAME ltime leach lday) ○ CAN lNOT lbe lmixed lwith lother linsulin s l 7. Why lis lit limportant lfor lnurses lto lknow lonset, lpeak, land lduration lof leach ltype lof linsulin? ● Onset lof laction ltells lyou lwhen lthe lpatient lhas lto leat l ● The lpeak lis lwhen lthe lpatient lis lat lgreatest lrisk lfor lhypoglycemia l 8. Describe lthe lsites land ladministration ltechniques lfor linsulin linjection. l lWhat llocal lskin lcomplications lcan loccur lwith lthe luse lof l“pork” linsulin, lnot lrotating lsites lor

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Wisdoms. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$23.74. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

75759 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Exam (elaborations)

NUR 317 Med Surg 1 Exam 3 Study Guide- Ch. 48, 49, 32, 37: Diabetes; Thyroid; Adrenal Gland; Hyper/hypotension; Vascular Disorders

Document information

Subjects

Written for

Seller

Reviews received

Content preview